Evidence map›Paper›PMID 35632805›Full record

ReviewViruses2022

The Contribution of Viral Proteins to the Synergy of Influenza and Bacterial Co-Infection.

Miriam Mikušová, Karolína Tomčíková, Katarína Briestenská, František Kostolanský, Eva Varečková

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Cooperation and cheating orchestrate Vibrio assemblages and polymicrobial synergy in oysters infected with OsHV-1 virus.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Miriam MikušováBiomedical Research Center of the Slovak Academy of Sciences, Institute of Virology, Dúbravská Cesta 9, 845 05 Bratislava, Slovakia.ORCID 0000-0002-9715-7017
Karolína TomčíkováBiomedical Research Center of the Slovak Academy of Sciences, Institute of Virology, Dúbravská Cesta 9, 845 05 Bratislava, Slovakia.ORCID 0000-0001-6988-9352
Katarína BriestenskáBiomedical Research Center of the Slovak Academy of Sciences, Institute of Virology, Dúbravská Cesta 9, 845 05 Bratislava, Slovakia.ORCID 0000-0003-0321-3565
František KostolanskýBiomedical Research Center of the Slovak Academy of Sciences, Institute of Virology, Dúbravská Cesta 9, 845 05 Bratislava, Slovakia.ORCID 0000-0003-4304-070X
Eva VarečkováBiomedical Research Center of the Slovak Academy of Sciences, Institute of Virology, Dúbravská Cesta 9, 845 05 Bratislava, Slovakia.ORCID 0000-0002-6386-651X
Biomedical Research Center of the Slovak Academy of Sciences · SK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A severe course of acute respiratory disease caused by influenza A virus (IAV) infection is often linked with subsequent bacterial superinfection, which is difficult to cure. Thus, synergistic influenza-bacterial co-infection represents a serious medical problem. The pathogenic changes in the infected host are accelerated as a consequence of IAV infection, reflecting its impact on the host immune response. IAV infection triggers a complex process linked with the blocking of innate and adaptive immune mechanisms required for effective antiviral defense. Such disbalance of the immune system allows for easier initiation of bacterial superinfection. Therefore, many new studies have emerged that aim to explain why viral-bacterial co-infection can lead to severe respiratory disease with possible fatal outcomes. In this review, we discuss the key role of several IAV proteins-namely, PB1-F2, hemagglutinin (HA), neuraminidase (NA), and NS1-known to play a role in modulating the immune defense of the host, which consequently escalates the development of secondary bacterial infection, most often caused by

Indexed as

Bacterial InfectionsCoinfectionInfluenza A virusInfluenza, HumanSuperinfectionAntiviral AgentsHumansViral ProteinsAntiviral AgentsViral Proteinsco-infectioninfluenza viral proteinsinfluenza virussecondary bacterial infectionStreptococcus pneumoniae

Identifiers

PMID35632805
PMCPMC9143653
OpenAlexW4280511278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.